Monthly Archives: October 2014

sphingotec and GeneNews Limited/Innovative Diagnostics Laboratory (IDL) Sign a Licensing and Cooperation Agreement for the U.S. Market

GeneNews/IDL will be first U.S. laboratory to offer sphingotec’s innovative breast cancer risk tests. Cambridge, Mass. – October 14, 2014 – SphingoTec GmbH, headquartered in Hennigsdorf, Germany with U.S. operations in Cambridge, Massachusetts, today announced that it has out-licensed two of its biomarker assays—sphingotest® pro-NT and sphingotest® pro-ENK—to GeneNews Limited (TSX:GEN). The biomarker assays will…
Read more